Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aractingi

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Bone Marrow Transplantation|June 1, 1997
PML is expressed in chronic graft-versus-host disease lesionsS Aractingi, H de Thé, E Gluckman, et al.
Annales De Dermatologie Et De Venereologie|November 19, 2017
[Dermatologic surgery, hemophilia and Von Willebrand disease]M Say, N Dupin, N Stieltjes, et al.
Dermatology (Basel, Switzerland)|January 1, 1993
Fusarium solani cutaneous infection in a neutropenic patientF Caux, S Aractingi, H Baurmann, et al.
Annals of Internal Medicine|June 15, 1994
Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 casesA Janin, G Socie, A Devergie, et al.
Acta Dermato-Venereologica|February 1, 1993
Persistent acantholytic dermatosis: sex-related differences in clinical presentation?M Mokni, S Aractingi, R Grossman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2012
Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathwayM P Rodero, A Prignon, M F Avril, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1993
[Epidermotropic T-cell gamma/delta lymphoma]S Aractingi, J P Marolleau, M F D'Agay, et al.
Archives of Dermatology|July 29, 1998
Role of drugs in cutaneous eruptions after chemotherapy for acute myelogenous leukemiaS Mansouri, L Dubertret, S Bastuji-Garin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 2, 2014
Long-term sustained lesion clearance from Lmax with imiquimod 3.75%, a new field-directed treatment for actinic keratosisG Gupta, E Stockfleth, K Peris, et al.
The British Journal of Dermatology|December 1, 2007
Sickle cell leg ulcers: a frequently disabling complication and a marker of severityM Halabi-Tawil, F Lionnet, R Girot, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|June 1, 1997
PML is expressed in chronic graft-versus-host disease lesionsS Aractingi, H de Thé, E Gluckman, et al.
Annales De Dermatologie Et De Venereologie|November 19, 2017
[Dermatologic surgery, hemophilia and Von Willebrand disease]M Say, N Dupin, N Stieltjes, et al.
Dermatology (Basel, Switzerland)|January 1, 1993
Fusarium solani cutaneous infection in a neutropenic patientF Caux, S Aractingi, H Baurmann, et al.
Annals of Internal Medicine|June 15, 1994
Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 casesA Janin, G Socie, A Devergie, et al.
Acta Dermato-Venereologica|February 1, 1993
Persistent acantholytic dermatosis: sex-related differences in clinical presentation?M Mokni, S Aractingi, R Grossman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2012
Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathwayM P Rodero, A Prignon, M F Avril, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1993
[Epidermotropic T-cell gamma/delta lymphoma]S Aractingi, J P Marolleau, M F D'Agay, et al.
Archives of Dermatology|July 29, 1998
Role of drugs in cutaneous eruptions after chemotherapy for acute myelogenous leukemiaS Mansouri, L Dubertret, S Bastuji-Garin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 2, 2014
Long-term sustained lesion clearance from Lmax with imiquimod 3.75%, a new field-directed treatment for actinic keratosisG Gupta, E Stockfleth, K Peris, et al.
The British Journal of Dermatology|December 1, 2007
Sickle cell leg ulcers: a frequently disabling complication and a marker of severityM Halabi-Tawil, F Lionnet, R Girot, et al.
Pageof 19